Search by Drug Name, NDC or Jcode
Internal Navigation
HCPCS Details
| HCPC | J9225 |
| Short Description | Vantas implant |
| Long Description | Histrelin implant (vantas), 50 mg |
| Pricing indicator | 51 |
| Coverage code | D |
| ASC payment group code | YY |
| BETOS2 code | O1D |
| Action code | N |
| Type of service | 1 |
| Effective date | 2008-01-01 |
| Date Added | 2006-01-01 |
Drug Details
-
Histrelin implant (Vantas) is used to treat the symptoms associated with advanced prostate cancer. Histrelin implant (Supprelin LA) is used to treat central precocious puberty (CPP; a condition causing children to enter puberty too soon, resulting in faster than normal bone growth and development of sexual characteristics) in girls usually between 2 and 8 years of age and in boys usually between 2 and 9 years of age. Histrelin implant is in a class of medications called gonadotropin-releasing hormone (GnRH) agonists. It works by decreasing the amount of certain hormones in the body.